Navigation Links
My Daily PACE Mobile Reminder Tool Available for People with Ulcerative Colitis
Date:4/2/2013

NEW YORK, April 2, 2013 /PRNewswire-iReach/ -- The Johns Hopkins University School of Medicine (JHUSOM) and DKBmed, LLC, have collaborated to create My Daily PACE, a mobile phone-based tool designed to help people with ulcerative colitis remember to take their medications and to track their symptoms. The tool is part of PACE UC: Persistence, Adherence, and Compliance Education in Ulcerative Colitis, an educational program created by JHUSOM and DKBmed. People with ulcerative colitis are encouraged to sign up for My Daily PACE, a free service that can be accessed by visiting http://www.mydailypace.org.

(Photo: http://photos.prnewswire.com/prnh/20130402/CG86842)

The first symptoms of ulcerative colitis (UC) are progressive loosening of the stool, abdominal pain, and changes in bowel habits, which can become quite difficult to tolerate in patients with severe disease. There are multiple types of medication for UC, ranging from drugs that reduce inflammation to those that alter the immune system. These medications need to be taken every day. But as few as 40% of patients with mild to moderate UC take their medication as prescribed, raising their risk of UC "flares."

My Daily PACE offers users the following features:

  • Daily text message reminders, which the subscriber can receive at a specified time
  • The ability for the subscriber to text back how he or she is feeling
  • Tracking of symptoms, which the user can choose to share with healthcare providers and/or family members

"Ulcerative colitis must be treated every day for life. A tool that can remind patients to take their medication is highly valuable and has the potential to enhance their quality of life by helping them manage their symptoms," explained Dean Beals , President and CEO of DKBmed.  PACE UC educator Steven Ross Brant , MD, Associate Professor of Medicine and Director of the Meyerhoff Inflammatory Bowel Disease Center at The Johns Hopkins University School of Medicine helped develop the symptom tracking function for both patients and doctors. With the patient's permission, clinicians can log in and track their patient's symptoms and measure adherence.

My Daily PACE is private. All data that a patient enters into My Daily PACE is encrypted, and only he or she can access it and decide who else can view it.

The program is supported by an educational grant from Shire Pharmaceuticals.

About DKBmed

DKBmed is an integrated, non-accredited, continuing medical education company operated by a team of experienced medical education. The goal of DKBmed is to provide health care professionals with effective medical education that closes identified knowledge/practice gaps to ensure optimal patient care.

Working with accredited providers, DKBmed develops a range of innovative educational programs and specializes in bringing new adult learning methodologies to the CME landscape. DKBmed was an early adopter of utilizing case scenarios with recorded and live actors, 3D animation, webcasts, podcasts, e-mail, and mobile phone applications for clinicians and patients. These forward-thinking approaches enable users to learn using the latest state-of-the-art techniques and to access educational programs in a manner that is most convenient and appropriate for them.

DKBmed's programs are accessible through the company's web site (www.dkbmed.com). They reach more than 30,000 clinicians specializing in a variety of areas, including neonatology, cystic fibrosis, infectious disease, dermatology, macular degeneration, rheumatoid arthritis, pulmonary disease, nephrology, hematology, transplantation, multiple sclerosis, gout, ulcerative colitis, depression, and pain management.

Media Contact: Dean Beals DKBmed, 646-336-6495, dbeals@dkbmed.com


News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE DKBmed
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Shows NxStage Daily Home Hemodialysis Patients More Likely to Receive Kidney Transplant
2. Pearl Therapeutics Phase 2b Twice-Daily Dosing Data Suggest Morning and Evening Benefit of PT003 in Patients with COPD
3. Six-Year Follow-Up Data for SPRYCEL®? (dasatinib) 100 mg Once Daily Demonstrates 71 Percent Overall Survival in Patients with Chronic-Phase Chronic Myeloid Leukaemia Resistant or Intolerant to Imatinib
4. Medical Device Daily Wins Prestigious SIPA Award for Outstanding Business Journalism
5. Daily Cocoa Flavanol Consumption Shown to Improve Cognitive Function in Older Adults
6. Sosei Group Corporation: Data at ERS Shows Efficacy of Once-daily COPD Portfolio Versus Comparators, Further Establishes Dual-bronchodilator QVA149
7. Sosei Group Corporation: QVA149 Filed as a Once-Daily Maintenance Treatment for COPD in Europe
8. Daiichi Sankyo Completes Enrolment in Hokusai - VTE, investigating once-daily Edoxaban in the Largest Single Phase 3 Study for the Treatment and Prevention of Recurrence of VTE
9. Medical Device Daily releases Med-Tech on a Mission: Strategies to Drive Innovation
10. U.S. Census Bureau Daily Feature for November 5
11. Sosei Group Corporation: QVA149 Filed by Licensing Partner as a Once-Daily Maintenance Treatment for COPD in Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Connecticut , 8 de dezembro de 2016  A Mederi Therapeutics ... terapia Stretta, um tratamento não cirúrgico para a doença do refluxo gastroesofágico (DRGE). ... ... Live Stretta procedure performed and ... of Endoscopy at Wuhan Union Hospital ...
(Date:12/8/2016)... , Dec. 8, 2016 Bodycad ... patents for improving the accuracy, reproducibility and speed ... in long and small bone orthopaedic applications. These ... to creating personalized orthopaedic restorations based on each ... orthopaedic restorations, the company harnesses the world,s first ...
(Date:12/8/2016)... 8, 2016  Valeant Pharmaceuticals International, Inc. (NYSE: ... today announced positive results from a Phase 3, ... the safety and efficacy of IDP-118 (halobetasol propionate ... psoriasis. Within the Phase 3 ... severe psoriasis, IDP-118 showed statistical significance to vehicle ...
Breaking Medicine Technology:
(Date:12/10/2016)... ... ... When faced with having to use a toilet away from home an inventor ... contamination of children when they use public toilets. This inspired her to design a ... , The patent-pending SANI-POCKET enables a person to use a public toilet in a ...
(Date:12/9/2016)... Cincinnati, Ohio (PRWEB) , ... December 09, 2016 ... ... production of miniature, folded, pharmaceutical inserts and outserts. As a means of ... This addition will enable Flottman to individually code professional inserts (PIs) and ...
(Date:12/9/2016)... PA (PRWEB) , ... December 09, 2016 , ... An ... permit amputees to safely ride all types of amusement park rides. , The patent-pending ... the unit is easy to use and could be set up in a matter ...
(Date:12/9/2016)... ... December 09, 2016 , ... "I had a terrible time ... Winchester, Va. "I thought that if the nebulizer had a more child-friendly design, then ... them." , He developed the patent-pending NEBY to avoid the need to deliver medication ...
(Date:12/8/2016)... ... December 08, 2016 , ... After ... officially opened registration today for its 33rd Annual Issues & Research Conference, ... , The theme of the conference is “Persistent Challenges and New Opportunities: Using ...
Breaking Medicine News(10 mins):